With the introduction of new antithrombotic medications, it is imperative that health care professionals understand clotting mechanisms and their relationship to the desired drug response.
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
CytoSorb is not yet approved in the United States. In the U.S. and Canada, CytoSorbents is developing the DrugSorb™-ATR antithrombotic removal system, an investigational device based on an equivalent ...
Using statins for the primary prevention of VTE may slightly reduce the incidence of VTE and all-cause mortality. However, this effect is likely too weak to be considered significant. Statin use may ...
The combined use of antiplatelet drugs acting through different mechanisms is important in antithrombotic treatment of patients with cardiovascular disease. The improvement of our knowledge on the ...
Winning ideas in the Health Tech Competition involve, engage or support patient treatment and solve a pervasive problem in antithrombotic, coronary artery disease/acute coronary syndrome, ...